Search for: "Pfizer, Inc." Results 661 - 680 of 1,512
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jul 2009, 8:00 am
AXCELIS TECHNOLOGIES, INC., a case involving the invocation of inspection rights to investigate the reasons why the board of directors of Axcelis did not accept the resignation of three directors who failed to receive majority support from shareholders voting in the election. [read post]
13 Jul 2020, 9:02 pm by News Desk
Based in Parsippany-Troy Hills, NJ,  Zoetis used to be a Pfizer subsidiary but is now an independent company. [read post]
8 Jul 2010, 5:00 am by Anapol Schwartz
West-Ward Pharmaceuticals, Pfizer, and Sagent Pharmaceuticals all recalled batches of Ondansetron prepared by Claris LifeSciences, Inc. after it was discovered that the batches were not sterile because they had not been prepared properly. [read post]
23 Nov 2010, 2:00 pm by admin
A $2.3 billion settlement with Pfizer Inc. marked the largest health care fraud settlement in history. [read post]
25 Jul 2008, 10:51 am
Pfizer and the other defendants in the Mirapex litigation are seeking a bifurcated trial plan. [read post]
9 Oct 2021, 9:48 am by Juvan Bonni
– Electrical and Computer Science Technologies Patent Attorney or Agent Duane Morris Nelson Mullins Hanley, Flight & Zimmerman, LLC – Foreign Filing Paralegal Metalenz Hanley, Flight & Zimmerman, LLC – Patent Associate Attorney Nyemaster Goode, PC Buchanan Ingersoll & Rooney PC Cabinet Beau de Loménie Norton Rose Fulbright Daly, Crowley, Mofford & Durkee, LLP Bainwood Huang Chernoff Vilhauer LLP Kennedy Lenart Spraggins LLP Kubota & Basol LLP Wells… [read post]
1 Dec 2011, 3:58 am by Lawrence B. Ebert
Bloomberg also reported: Pfizer has struck deals with companies including Catalyst Health Solutions Inc. and Coventry Health Care Inc. to prevent generic Lipitor from reaching some patients until the end of May 2012. [read post]
The plaintiffs in related cases originally filed their complaints in California state court alleging Lipitor, a prescription drug developed and manufactured by the defendant Pfizer, Inc. [read post]
13 Mar 2011, 1:50 pm by Lawrence B. Ebert
”); Pfizer, Inc., 480 F.3d at 1372 (“[W]e hold that even if Pfizer showed that amlodipine besylate exhibits unexpectedly superior results, this secondary consideration does not overcome the strong showing of obviousness in this case. . . . [read post]